The evaluation of TSPO density is now well-recognized as a relevant index of microglial activation (Chen and Guilarte, 2008) and a great number of literature data have to date reported an upregulation of this biomarker in Alzheimer’s disease (Tournier et al., 2020). The gene discussed is TSPO; the disease is early-onset autosomal dominant Alzheimer disease.